Statements (21)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:activeIngredient |
gptkb:netarsudil
|
| gptkbp:approvalYear |
2017
|
| gptkbp:approvedBy |
gptkb:FDA
|
| gptkbp:ATCCode |
S01EX05
|
| gptkbp:drugClass |
ophthalmic antihypertensive agent
|
| gptkbp:form |
eye drops
|
| https://www.w3.org/2000/01/rdf-schema#label |
Rhopressa
|
| gptkbp:legalStatus |
Rx-only (US)
|
| gptkbp:manufacturer |
gptkb:Aerie_Pharmaceuticals
|
| gptkbp:mechanismOfAction |
Rho kinase inhibitor
norepinephrine transporter inhibitor |
| gptkbp:prescriptionStatus |
prescription only
|
| gptkbp:routeOfAdministration |
ophthalmic
|
| gptkbp:sideEffect |
eye pain
conjunctival hyperemia corneal verticillata |
| gptkbp:usedFor |
treatment of ocular hypertension
treatment of open-angle glaucoma |
| gptkbp:bfsParent |
gptkb:Aerie_Pharmaceuticals
|
| gptkbp:bfsLayer |
7
|